Zions Bancorporation N.A. Purchases 4,057 Shares of Azenta, Inc. (NASDAQ:AZTA)

Zions Bancorporation N.A. raised its stake in Azenta, Inc. (NASDAQ:AZTA) by 20.4% in the third quarter, Holdings Channel reports. The fund owned 23,904 shares of the company’s stock after purchasing an additional 4,057 shares during the quarter. Zions Bancorporation N.A.’s holdings in Azenta were worth $1,158,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Azenta by 1.9% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after acquiring an additional 100,826 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Azenta by 16.5% in the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after buying an additional 421,719 shares during the period. Allspring Global Investments Holdings LLC increased its stake in shares of Azenta by 16.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock valued at $62,917,000 after buying an additional 183,040 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Azenta by 3.8% in the second quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company’s stock valued at $27,120,000 after buying an additional 18,680 shares during the period. Finally, Federated Hermes Inc. increased its position in Azenta by 6.3% during the 2nd quarter. Federated Hermes Inc. now owns 432,506 shares of the company’s stock valued at $22,758,000 after purchasing an additional 25,586 shares during the period. Institutional investors own 99.08% of the company’s stock.

Insider Buying and Selling at Azenta

In other Azenta news, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the transaction, the chief financial officer now directly owns 24,604 shares in the company, valued at approximately $1,074,702.72. This trade represents a 6.09 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.77% of the company’s stock.

Analyst Upgrades and Downgrades

AZTA has been the subject of a number of recent analyst reports. Evercore ISI decreased their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research report on Tuesday, October 1st. Needham & Company LLC decreased their target price on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $63.60.

Azenta Stock Down 4.2 %

Shares of AZTA opened at $42.63 on Friday. Azenta, Inc. has a 12-month low of $40.24 and a 12-month high of $69.16. The business’s fifty day moving average is $45.68 and its 200 day moving average is $50.54. The stock has a market cap of $2.09 billion, a P/E ratio of -14.35 and a beta of 1.48.

Azenta (NASDAQ:AZTA) last issued its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.08. Azenta had a positive return on equity of 0.98% and a negative net margin of 25.01%. The company had revenue of $170.00 million for the quarter, compared to analysts’ expectations of $169.66 million. During the same period last year, the business earned $0.13 EPS. Azenta’s quarterly revenue was down 1.2% compared to the same quarter last year. On average, analysts expect that Azenta, Inc. will post 0.42 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.